Trial Review

Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT01368367




Registration number
NCT01368367
Ethics application status
Date submitted
27/05/2011
Date registered
7/06/2011
Date last updated
7/06/2011

Titles & IDs
Public title
Exercise Training Post Burn Injury
Scientific title
Safety and Efficacy of Exercise Training Post Burn Injury: a Randomized Controlled Trial
Secondary ID [1] 0 0
ETPB1
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Burns 0 0
Condition category
Condition code
Injuries and Accidents 0 0 0 0
Burns

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Other interventions - Intensive exercise

Active comparator: Intensive exercise group -

Placebo comparator: Stretch exercise only -


Other interventions: Intensive exercise
Both groups, stretching exercise monitored once per week Intensive exercise group An aerobic and resisted exercise program for a minimum of three times per week for a total of approximately 60 minutes per session for six weeks. Aerobic exercise will be conducted on a treadmill, exercise bike or arm ergometer at an intensity of 80 % of VO2peak during initial assessment. For resistance exercise, the three repetition maximum (3RM) (maximum weight able to be lifted a maximum of 3 times) will be established and then resisted exercise will be commenced at 60% of the 3RM in the first week. Resisted exercise will then be progressed weekly by 5-10% by increasing the number of repetitions or the weights lifted. All resisted exercises will be done using variable resistance machines or free weights.
Intervention code [1] 0 0
Other interventions
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Burns Specific Health Scale - Abbreviated (BSHS-A)
Timepoint [1] 0 0
Change from baseline to six weeks, change from 6 weeks to 12 weeks
Secondary outcome [1] 0 0
The modified shuttle walk test (MSWT)
Timepoint [1] 0 0
Change from baseline to six weeks, change from 6 weeks to 12 weeks
Secondary outcome [2] 0 0
VO2peak (ie the volume of oxygen consumed by the cells at the most intensive level during the exercise test)
Timepoint [2] 0 0
Change from baseline to six weeks, change from 6 weeks to 12 weeks
Secondary outcome [3] 0 0
Resting heart rate (beats/minute)
Timepoint [3] 0 0
Change from baseline to six weeks, change from 6 weeks to 12 weeks
Secondary outcome [4] 0 0
Muscle strength
Timepoint [4] 0 0
Change from baseline to six weeks, change from 6 weeks to 12 weeks
Secondary outcome [5] 0 0
Grip strength
Timepoint [5] 0 0
Change from baseline to six weeks, change from 6 weeks to 12 weeks
Secondary outcome [6] 0 0
QuickDash
Timepoint [6] 0 0
Change from baseline to six weeks, change from 6 weeks to 12 weeks
Secondary outcome [7] 0 0
The Lower Extremity Functional Scale (LEFS)
Timepoint [7] 0 0
Change from baseline to six weeks, change from 6 weeks to 12 weeks

Eligibility
Key inclusion criteria
* Burns greater than 20% total body surface area
* 18 years of age and over
* English speaking
* Post final grafting procedure
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
* Accompanying anoxic brain injury
* Cardiac disease or injury (American College of Sports medicine ACSM criteria)
* Quadriplegia
* Severe behaviour or cognitive disorders
* Compassionate care only

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?


The people assessing the outcomes
The people analysing the results/data
Intervention assignment
Parallel
Other design features
Phase
Not applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
UNKNOWN
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
1/12/2007
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
1/12/2012
Actual
Sample size
Target
36
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
QLD
Recruitment hospital [1] 0 0
Royal Brisbane & Womens Hospital - Brisbane
Recruitment postcode(s) [1] 0 0
4029 - Brisbane

Funding & Sponsors
Primary sponsor type
Other
Name
The University of Queensland
Address
Country
Other collaborator category [1] 0 0
Government body
Name [1] 0 0
Royal Brisbane and Women's Hospital
Address [1] 0 0
Country [1] 0 0

Ethics approval
Ethics application status

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

No documents have been uploaded by study researchers.

Results not provided in https://clinicaltrials.gov/study/NCT01368367